TGFB1 and neoplasm: However, MSCs is a double edge sword in cancer therapy, in which MSCs can differentiate into cancer-associated fibroblasts (CAFs) in response to TGF-β released from tumour cells, leading to the promotion of tumour growth and progression (44, 45).